Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 7, 2015; 21(25): 7869-7876
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7869
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7869
Table 1 Demographics and baseline characteristics of patients
| Characteristic | Compensated cirrhosis group(n = 96) | Decompensated cirrhosis group(n = 108) | P value |
| Age (yr) | 33.4 ± 10.6 | 42.4 ± 14.5 | < 0.05 |
| Male | 64 (67) | 84 (78) | 0.085 |
| HBeAg-positive | 72 (75) | 46 (43) | < 0.05 |
| HBV DNA (log10 copies/mL) | 6.5 ± 1.3 | 5.6 ± 1.5 | 0.077 |
| ALT (IU/L) | 131.4 ± 125.7 | 72.5 ± 63.1 | < 0.05 |
| HBV genotype | |||
| B | 40 (42) | 16 (15) | < 0.05 |
| C | 48 (50) | 78 (72) | < 0.05 |
| Other (A and D) | 8 (8) | 14 (13) | 0.367 |
- Citation: Xu Y, Zhang YG, Wang X, Qi WQ, Qin SY, Liu ZH, Jiao J, Wang JB. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. World J Gastroenterol 2015; 21(25): 7869-7876
- URL: https://www.wjgnet.com/1007-9327/full/v21/i25/7869.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i25.7869